(Q36730634)

15 August 2017

1 reference

title

Mapping translational research in personalized therapeutics: from molecular markers to health policy (English)

1 reference

15 August 2017

2

Bryn Williams-Jones

0 references

Vural Özdemir

series ordinal

1

object named as

Vural Ozdemir

1 reference

15 August 2017

5

Béatrice Godard

1 reference

15 August 2017

Dan M Cooper

3

1 reference

15 August 2017

Toshiyuki Someya

series ordinal

4

1 reference

15 August 2017

publication date

1 February 2007

1 reference

15 August 2017

1 reference

15 August 2017

volume

8

1 reference

15 August 2017

issue

2

1 reference

15 August 2017

page(s)

177-185

1 reference

Genetic basis of toxic reactions to drugs and chemicals.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.2.177

Knowledge commons or economic engine--what's a university for?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.2.177

Shifting emphasis from pharmacogenomics to theragnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.2.177

Biomarkers in cancer screening, research and detection: present and future: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.2.177

Metabonomics: a platform for studying drug toxicity and gene function

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.2.177

CYP2C9 genetic variants and losartan oxidation in a Turkish population.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.2.177

Pharmacogenetics: the bioethical problem of DNA investment banking

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.2.177

Strategies for consulting with the community: the cases of four large-scale genetic databases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.2.177

Data storage and DNA banking for biomedical research: informed consent, confidentiality, quality issues, ownership, return of benefits. A professional perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.2.177

Candidate gene case-control studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.2.177

21 January 2018

Pharmacogenomics in Asia

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.2.177

Pharmacogenomics and individualized drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.2.177

Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.2.177

Pharmacogenetics goes genomic

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.2.177

Haplotypes and the systematic analysis of genetic variation in genes and genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.2.177

Pharmacogenomics in admixed populations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.2.177

Beyond consent: ethical and social issues in genetic testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.2.177

Pharmacogenetics of the cytochromes P450.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.2.177

Genebanks: A Comparison of Eight Proposed International Genetic Databases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.2.177

Guidelines for disclosing genetic information to family members: from development to use.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.2.177

Data withholding in genetics and the other life sciences: prevalences and predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.2.177

Pharmacogenomics, informatics, and individual drug therapy in psychiatry: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.2.177

Priorities and standards in pharmacogenetic research

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.2.177

Pharmacogenomic-guided rational therapeutic drug monitoring: conceptual framework and application platforms for atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.2.177

Confounding, ascertainment bias, and the blind quest for a genetic 'fountain of youth'.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.2.177

Adding pharmacogenetics information to drug labels: lessons learned

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.2.177

The path from genome-based research to population health: development of an international public health genomics network

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.2.177

Geneticization, medicalisation and polemics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.2.177

‘Be ready against cancer, now’: direct-to-consumer advertising for genetic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.2.177

Putting pharmacogenetics into practice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.2.177

21 January 2018

Identifiers

DOI

10.2217/14622416.8.2.177

1 reference

15 August 2017

1 reference